Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer (Q43635626)
Jump to navigation
Jump to search
scientific article published in July 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer |
scientific article published in July 2001 |
Statements
1 reference
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer (English)
1 reference
1 reference
I O Ellis
1 reference
J F Robertson
1 reference
R I Nicholson
1 reference
1 July 2001
1 reference
1 reference
95
1 reference
4
1 reference
247-254
1 reference
Identifiers
1 reference
1 reference